Rohin Mhatre
CIK 1798735 · View on SEC EDGAR ↗
Insider
First SEC filing: June 9, 2026 · Latest: June 9, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 13 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | RGEN | A | 2,239 | — | — | 2,239 Direct | — | Acquired | (price as of 2026-08-20) |
| May 14, 2026 | RGEN | A | 995 | — | — | 5,014 Direct | +24.76% | Acquired | (price as of 2026-08-20) |
| May 15, 2025 | RGEN | A | 1,800 | — | — | 1,800 Direct | — | Acquired | (price as of 2026-08-20) |
| May 15, 2025 | RGEN | A | 973 | — | — | 4,019 Direct | +31.94% | Acquired | (price as of 2026-08-20) |
| May 16, 2024 | RGEN | A | 1,376 | — | — | 1,376 Direct | — | Acquired | (price as of 2026-08-20) |
| May 16, 2024 | RGEN | A | 701 | — | — | 3,046 Direct | +29.89% | Acquired | (price as of 2026-08-20) |
| May 18, 2023 | RGEN | A | 1,487 | — | — | 1,487 Direct | — | Acquired | (price as of 2026-08-20) |
| May 18, 2023 | RGEN | A | 686 | — | — | 2,345 Direct | +41.35% | Acquired | (price as of 2026-08-20) |
| May 26, 2022 | RGEN | A | 2,920 | — | — | 2,920 Direct | — | Acquired | (price as of 2026-08-20) |
| May 26, 2022 | RGEN | A | 1,202 | — | — | 1,659 Direct | +263.02% | Acquired | (price as of 2026-08-20) |
| May 13, 2021 | RGEN | A | 1,151 | — | — | 1,151 Direct | — | Acquired | (price as of 2026-08-20) |
| May 13, 2021 | RGEN | A | 457 | — | — | 457 Direct | — | Acquired | (price as of 2026-08-20) |
| March 1, 2020 | RGEN | A | 3,452 | — | — | 3,452 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | RGEN | Stock Option (Right to Buy) | Common Stock (2,239) | $103.38 | May 14, 2036 | 2,239 | Acquired |
| May 15, 2025 | RGEN | Stock Option (Right to Buy) | Common Stock (1,800) | $123.26 | May 15, 2035 | 1,800 | Acquired |
| May 16, 2024 | RGEN | Stock Option (Right to Buy) | Common Stock (1,376) | $171.03 | May 16, 2034 | 1,376 | Acquired |
| May 18, 2023 | RGEN | Stock Option (Right to Buy) | Common Stock (1,487) | $156.63 | May 18, 2033 | 1,487 | Acquired |
| May 26, 2022 | RGEN | Stock Option (Right to Buy) | Common Stock (2,920) | $159.17 | May 26, 2032 | 2,920 | Acquired |
| May 13, 2021 | RGEN | Stock Option (Right to Buy) | Common Stock (1,151) | $169.65 | May 13, 2031 | 1,151 | Acquired |
| March 1, 2020 | RGEN | Stock Option (Right to Buy) | Common Stock (3,452) | $85.60 | March 1, 2030 | 3,452 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.